Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -54.45% is 60% below its 5-year average of -33.99%, near the low end of its 5-year range (-80.28%–10.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.32% below its 12-month average of -47.21%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -54.45%.
RETURN ON EQUITY (ROE)
-54.45%
RETURN ON EQUITY (ROE) AVG TTM
-47.21%
RETURN ON EQUITY (ROE) AVG 3Y
-42.90%
RETURN ON EQUITY (ROE) AVG 5Y
-33.99%
RETURN ON EQUITY (ROE) AVG 10Y
-69.77%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.32%
CURRENT VS 3Y AVG
-26.92%
CURRENT VS 5Y AVG
-60.19%
CURRENT VS 10Y AVG
+21.96%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-29.60%
vs the sector median at left
Lipocine Inc.
Market Cap
$17.11M
Return on Equity (ROE)
-54.45%
TTM Avg
-47.21%
3Y Avg
-42.90%
5Y Avg
-33.99%
Market Cap
$17.14M
Return on Equity (ROE)
-125.30%
TTM Avg
118.50%
3Y Avg
7030.24%
5Y Avg
4638.47%
Market Cap
$16.75M
Return on Equity (ROE)
-101.76%
TTM Avg
-188.04%
3Y Avg
-167.76%
5Y Avg
-134.95%
Market Cap
$16.67M
Return on Equity (ROE)
-71.57%
TTM Avg
-65.12%
3Y Avg
-85.39%
5Y Avg
-90.29%
Market Cap
$16.53M
Return on Equity (ROE)
-170.55%
TTM Avg
-79.16%
3Y Avg
-71.01%
5Y Avg
-42.13%
Market Cap
$17.68M
Return on Equity (ROE)
-34.50%
TTM Avg
-796.82%
3Y Avg
-138.82%
5Y Avg
-407.45%
Market Cap
$16.50M
Return on Equity (ROE)
N/A
TTM Avg
-416.37%
3Y Avg
-259.03%
5Y Avg
-190.00%
Market Cap
$17.84M
Return on Equity (ROE)
-117.98%
TTM Avg
-84.94%
3Y Avg
-64.05%
5Y Avg
-76.29%
Market Cap
$17.99M
Return on Equity (ROE)
N/A
TTM Avg
-3014.83%
3Y Avg
-1589.49%
5Y Avg
-1032.64%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lipocine Inc. (LPCN) | $17.11M | -54.45% | -47.21% | -42.90% | -33.99% |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | -125.30% | 118.50% | 7030.24% | 4638.47% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | -101.76% | -188.04% | -167.76% | -134.95% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.67M | -71.57% | -65.12% | -85.39% | -90.29% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.53M | -170.55% | -79.16% | -71.01% | -42.13% |
| PAVmed Inc. (PAVM)vs › | $17.68M | -34.50% | -796.82% | -138.82% | -407.45% |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | N/A | -416.37% | -259.03% | -190.00% |
| Cosmos Health Inc. (COSM)vs › | $17.84M | -117.98% | -84.94% | -64.05% | -76.29% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | N/A | -3014.83% | -1589.49% | -1032.64% |
| BioCardia, Inc. (BCDA)vs › | $15.79M | -271.81% | -934.34% | -347.56% | -265.02% |
ROE
-54.4%
ROA
-49.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -54.45% |
| 2026-03-31 | -50.08% |
| 2025-12-31 | -66.50% |
| 2025-09-30 | -38.72% |
| 2025-06-30 | -26.31% |
| 2025-03-31 | -27.97% |
| 2024-12-31 | 0.04% |
| 2024-09-30 | -21.22% |
| 2024-06-30 | -40.02% |
| 2024-03-31 | -37.44% |
| 2023-12-31 | -80.28% |
| 2023-09-30 | -72.50% |
| 2023-06-30 | -42.23% |
| 2023-03-31 | -34.86% |
| 2022-12-31 | -30.19% |
| 2022-09-30 | 10.88% |
| 2022-06-30 | 8.58% |
| 2022-03-31 | -1.78% |
| 2021-12-31 | -1.39% |
| 2021-09-30 | -54.16% |
| 2021-06-30 | -53.16% |
| 2021-03-31 | -43.79% |
| 2020-12-31 | -136.65% |
| 2020-09-30 | -136.10% |
| 2020-06-30 | -141.33% |
| 2020-03-31 | -237.36% |
| 2019-12-31 | -206.87% |
| 2019-09-30 | -172.42% |
| 2019-06-30 | -125.27% |
| 2019-03-31 | -96.92% |
| 2018-12-31 | -123.60% |
| 2018-09-30 | -117.04% |
| 2018-06-30 | -115.34% |
| 2018-03-31 | -113.01% |
| 2017-12-31 | -110.55% |
| 2017-09-30 | -78.32% |
| 2017-06-30 | -68.21% |
| 2017-03-31 | -67.63% |
| 2016-12-31 | -72.92% |
| 2016-09-30 | -73.76% |
| 2016-06-30 | -77.29% |
| 2016-03-31 | -62.22% |
| 2015-12-31 | -43.37% |
| 2015-09-30 | -38.09% |
| 2015-06-30 | -29.42% |
| 2015-03-31 | -76.14% |
| 2014-12-31 | -77.29% |
| 2014-09-30 | -69.17% |
| 2014-06-30 | -59.45% |
| 2014-03-31 | -35.73% |
| 2013-12-31 | -23.63% |
| 2013-09-30 | -19.85% |
